Citigroup’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.94M Buy
+20,500
New +$3.33M ﹤0.01% 2292
2024
Q1
– Sell
-23,000
Closed -$4.14M – 5819
2023
Q4
$4.14M Buy
+23,000
New +$3.58M ﹤0.01% 1717

Other funds holding RGEN

Citigroup's RGEN Position: Q3 2026 in Review

Citigroup reduced its Repligen (RGEN) stake by 34% in Q3 2026, selling an estimated $1.07M and leaving 12,895 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Citigroup first reported a position in RGEN in Q2 2013 and has held it in 54 quarters since. The position peaked at $13.9M in Q3 2024. 403 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Citigroup held 12,895 shares of Repligen worth $2.48M as of Q3 2026.
  • Citigroup sold 6,566 Repligen shares in Q3 2026, an estimated $1.07M.
  • Repligen made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #2651 holding.
  • Citigroup first reported a position in Repligen in Q2 2013 and has held it in 54 quarters since.
  • Citigroup's Repligen position peaked at $13.9M in Q3 2024.
  • 403 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.